Boston, Massachusetts, USA – October 8, 2024 – ArisGlobal, an innovative technology company at the forefront of life sciences and creator of LifeSphere®, today announced the successful implementation of LifeSphere® MultiVigilance by Gedeon Richter, a global specialty pharmaceutical company. The adoption of this state-of-the-art platform marks an important step in streamlining and modernizing pharmacovigilance operations for the global pharma organization, highlighting the impact of LifeSphere’s advanced safety case processing capabilities.
By moving from legacy systems to LifeSphere® MultiVigilance, the organization anticipates significant efficiency gains. The LifeSphere platform is projected to process approximately 16,000 safety cases in the first year, scaling to 18,000 cases annually by 2027. This deployment is an example of how LifeSphere helps life sciences companies enhance their safety operations while preparing for future demands.
“Innovation on behalf of our patients and employees around the world is a commitment for us. We are proud to deploy the latest LifeSphere technologies to aide our internal PV teams; increasing efficiency and allowing our team to focus more on proactive safety measures and strategic decision-making, rather than being tied down by manual processes, ultimately benefits our patients,” shared Attila Olah, Head of Global Patient Safety at Gedeon Richter. “Throughout the implementation, collaboration and communication between our team and ArisGlobal was seamless, which led to a successful and effective go-live. We are excited to realize the value LifeSphere brings to our processes and new opportunities the technology unlocks.”
LifeSphere® MultiVigilance automates and optimizes complex pharmacovigilance workflows, enabling organizations to manage drug safety with greater efficiency, reduced costs, and improved data accuracy. The platform is designed to support growing case volumes and regulatory requirements, ensuring that companies can maintain the highest safety standards while scaling their operations.
“Gedeon Richter is a rapidly evolving business, and we admire their commitment to leveraging new and proven technology. As their case volume expands year-over-year, their team is getting ahead of the curve by deploying cloud-based systems to leverage automation, driving efficiencies that will benefit as they prepare for continued growth,” stated Steve Nuckols, Chief Customer Officer at ArisGlobal. “We’re looking forward to our continued partnership with their team to deploy the latest technology for pharmaceutical organizations to drive agility, efficiency, and competitive advantage.”
LifeSphere® MultiVigilance is a leading pharmacovigilance solution that automates case processing and regulatory reporting. The platform’s ability to streamline drug safety workflows allows organizations to achieve compliance with global regulations while reducing operational overhead. LifeSphere empowers pharmaceutical companies to improve safety outcomes, enhance operational efficiency, and ensure seamless regulatory compliance. ArisGlobal is committed to helping life sciences companies achieve innovation in their drug safety operations by providing cutting-edge technology solutions.
About ArisGlobal
ArisGlobal, a leading innovative life sciences technology company and creator of LifeSphere®, is transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market. Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan, and China. For more updates, follow ArisGlobal on LinkedIn or visit us at www.arisglobal.com.
About Gedeon Richter
Gedeon Richter is a leading multinational pharmaceutical company headquartered in Budapest, Hungary. With a focus on innovation and quality, the company is committed to improving patient health worldwide through the development, manufacturing, and distribution of high-quality pharmaceuticals.
